πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,157 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9974868

Octapod iron oxide nanoparticles as high performance T2 contrast agents for magnetic reson

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9974796

Inhibitors of the plasmodial surface anion channel as antimalarials

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9974789

Substituted pyrazolopyrimidines as glucocerebrosidase activators

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9974801

Methods of treating and preventing diseases and disorders of the central nervous system

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9968693

Small molecule imaging of fungi by positron emission tomography scanning

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9963450

A3 adenosine receptor agonists

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9956278

Multivalent meningococcal conjugates and methods for preparing conjugates

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9951311

Agents and methods to elicit anti-tumor immune response

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9944927

Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9937217

Method of inhibiting ABCG2 and related treatments

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9937196

Genomic sequence of avian paramyxovirus type 2 and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9937191

Inhibition of HIV infection through chemoprophylaxis

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9931393

Immunogenic JC polyomavirus compositions and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9932406

Human monoclonal antibodies specific for glypican-3 and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9931377

Cell expressing complexes of IL-15 and IL-15Ralpha

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9919058

Polyketal particles including a CpG oligodeoxynucleotide for the treatment of lung cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9920296

Paenibacillus alvei strain TS-15 and its use in controlling pathogenic organisms on crops

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC Β· Granted Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9908841

Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in tr

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9902734

Nicotinic acetylcholine receptor agonists

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9896509

Use of antagonists of the interaction between HIV GP120 and Ξ±4Ξ²7 integrin

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9890369

Cytolethal distending toxin subunit B conjugated or fused to Bacillus anthracis toxin leth

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9889115

Fitness assay and associated methods

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9884104

Live attenuated virus vaccines for la crosse virus and other bunyaviridae

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9879231

Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertio

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted